CapVest Partners has signed an agreement with Bain Capital and Cinven to acquire a majority stake in STADA Arzneimittel AG, a healthcare and pharmaceuticals company specializing in Consumer Healthcare, Generics, and Specialty Pharmaceuticals.
Located in Bad Vilbel, Germany, STADA has evolved from a traditional generics business into a diversified global healthcare platform since its acquisition by Bain Capital and Cinven in 2017. The company has seen significant growth, generating over €4 billion in revenue and achieving a compound annual net sales growth rate of 9%, all while employing approximately 11,600 people worldwide.
CapVest is well-positioned to support STADA’s next phase of growth. Bain Capital and Cinven will retain minority stakes in STADA after the transaction, highlighting their continued confidence in the company.
The terms of the deal remain undisclosed and are subject to regulatory approvals, with closing anticipated in early 2026.
Advisors: Lead financial advisors to CapVest were Canson Capital Partners and Centerview Partners.
KEY QUOTES:
“We have admired STADA for several years, including its deep heritage, leading product portfolio and a culture underpinned by caring for people’s health. Peter and the entire STADA team have a best-in-class track record of performance. STADA is a unique strategic platform through which we will leverage our significant healthcare and consumer expertise to accelerate the development of the company in Germany and internationally. We intend to deploy significant new capital towards this objective. We look forward to working with Peter Goldschmidt and his team as custodians of this great company in its next phase of development.”
Matthew Fargie of CapVest
“CapVest’s focus on working closely with management in transforming the size and scale of its portfolio companies through significant capital investment, a combination of organic and acquisition led growth, operational excellence, and long-term value creation reflects the same principles that have underpinned STADA’s success to date. With their deep knowledge in the healthcare and pharmaceuticals markets, CapVest is an ideal next partner to work with us to capitalise on the many opportunities emerging in our sector and realise our ambitious plans for the company. Cinven and Bain Capital have been excellent partners on our journey to become a global leader in Consumer Healthcare, Generics and Specialty Pharmaceuticals. Their support and conviction in our vision enabled us to accelerate growth, innovate, and expand internationally.”
Peter Goldschmidt, Chief Executive Officer of STADA
